Literature DB >> 6148751

Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

J B Gibbs, I S Sigal, M Poe, E M Scolnick.   

Abstract

The 21-kilodalton protein (p21) encoded by normal cellular Harvey-ras has been expressed in Escherichia coli as a fusion protein by using the pUC8 vector and has been purified to greater than 95% homogeneity by ion-exchange chromatography and gel filtration. The purified protein molecules possess intrinsic GTPase activity on the basis of the following criteria: (i) elution of the GTPase activity with p21 GDP-binding activity in two different chromatography systems, (ii) parallel thermal inactivation of GTPase activity and p21 GTP-binding activity, and (iii) immunoprecipitation of the GTPase activity with monoclonal antibodies to p21. At 37 degrees C, the rate of GTP hydrolysis by the purified normal p21 assayed in solution was 5.3-6.6 mmol/min per mol of p21. The rate of GTP hydrolysis by a form of p21 [Val12] encoded by a human oncogene was significantly lower (1.4-1.9 mmol/min per mol of p21). The presence of a threonine phosphate acceptor site at residue 59 also decreased p21 GTPase activity. For regulatory proteins that use GTP as part of their biochemical mechanism, the hydrolysis of GTP to GDP reverses the biological activity of the respective proteins. The observation that oncogenic forms of p21 lose GTPase activity suggests that GTP hydrolysis may be a biochemical event that inactivates the growth-promoting effects of a p21 X GTP complex.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148751      PMCID: PMC391779          DOI: 10.1073/pnas.81.18.5704

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Plasmids of Escherichia coli as cloning vectors.

Authors:  F Bolivar; K Backman
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Hydrolysis of GTP by elongation factor Tu can be induced by monovalent cations in the absence of other effectors.

Authors:  O Fasano; E De Vendittis; A Parmeggiani
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

Review 3.  Protein biosynthesis.

Authors:  J Lucas-Lenard
Journal:  Annu Rev Biochem       Date:  1971       Impact factor: 23.643

4.  Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses.

Authors:  E M Scolnick; A G Papageorge; T Y Shih
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

6.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus.

Authors:  E H Chang; M E Furth; E M Scolnick; D R Lowy
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

7.  Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; I Pastan; T Y Shih; E M Scolnick
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

8.  Assembly of microtubule protein: role of guanosine di- and triphosphate nucleotides.

Authors:  M F Carlier; D Pantaloni
Journal:  Biochemistry       Date:  1982-03-16       Impact factor: 3.162

9.  The coupling with polypeptide synthesis of the GTPase activity dependent on elongation factor G.

Authors:  G Chinali; A Parmeggiani
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

10.  Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.

Authors:  D DeFeo; M A Gonda; H A Young; E H Chang; D R Lowy; E M Scolnick; R W Ellis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  184 in total

Review 1.  Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway.

Authors:  D W End
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

Review 2.  Molecular biology in medicine.

Authors:  B D Young
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 3.  MicroRNA-Based Therapeutic Strategies for Targeting Mutant and Wild Type RAS in Cancer.

Authors:  Sriganesh B Sharma; John Michael Ruppert
Journal:  Drug Dev Res       Date:  2015-08-18       Impact factor: 4.360

4.  Transfection of insulin-producing cells with a transforming c-Ha-ras oncogene stimulates phospholipase C activity.

Authors:  P O Berggren; A Hallberg; N Welsh; P Arkahammar; T Nilsson; M Welsh
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

Review 5.  Posttranslational Modifications of RAS Proteins.

Authors:  Ian Ahearn; Mo Zhou; Mark R Philips
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

6.  The H-ras oncogene product p21 and prognosis in human breast cancer.

Authors:  D M Watson; R A Elton; W J Jack; J M Dixon; U Chetty; W R Miller
Journal:  Breast Cancer Res Treat       Date:  1991 Jan-Feb       Impact factor: 4.872

7.  Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21.

Authors:  J Ma; M Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

8.  ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins.

Authors:  D C Fry; S A Kuby; A S Mildvan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.

Authors:  J J O'Leary; R J Landers; I Silva; V Uhlmann; M Crowley; I Healy; K Luttich
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 10.  Ras oncogenes: split personalities.

Authors:  Antoine E Karnoub; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.